DK163733B - Chromon- og thiochromonsubstituerede 1,4-dihydropyridinderivater, laegemidler indeholdende disse derivater og laegemidlernes fremstilling - Google Patents

Chromon- og thiochromonsubstituerede 1,4-dihydropyridinderivater, laegemidler indeholdende disse derivater og laegemidlernes fremstilling Download PDF

Info

Publication number
DK163733B
DK163733B DK145384A DK145384A DK163733B DK 163733 B DK163733 B DK 163733B DK 145384 A DK145384 A DK 145384A DK 145384 A DK145384 A DK 145384A DK 163733 B DK163733 B DK 163733B
Authority
DK
Denmark
Prior art keywords
compounds
carbon atoms
formula
alkyl
derivatives
Prior art date
Application number
DK145384A
Other languages
Danish (da)
English (en)
Other versions
DK145384A (da
DK145384D0 (da
Inventor
Siegfried Goldmann
Gerhard Franckowiak
Matthias Schramm
Guenter Thomas
Rainer Gross
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK145384D0 publication Critical patent/DK145384D0/da
Publication of DK145384A publication Critical patent/DK145384A/da
Publication of DK163733B publication Critical patent/DK163733B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK145384A 1983-03-25 1984-02-29 Chromon- og thiochromonsubstituerede 1,4-dihydropyridinderivater, laegemidler indeholdende disse derivater og laegemidlernes fremstilling DK163733B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833311005 DE3311005A1 (de) 1983-03-25 1983-03-25 Chromon- und thiochromonsubstituierte 1,4-dihydropyridinderivate, mehrere verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3311005 1983-03-25

Publications (3)

Publication Number Publication Date
DK145384D0 DK145384D0 (da) 1984-02-29
DK145384A DK145384A (da) 1984-09-26
DK163733B true DK163733B (da) 1992-03-30

Family

ID=6194712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK145384A DK163733B (da) 1983-03-25 1984-02-29 Chromon- og thiochromonsubstituerede 1,4-dihydropyridinderivater, laegemidler indeholdende disse derivater og laegemidlernes fremstilling

Country Status (14)

Country Link
US (1) US4540789A (ja)
EP (1) EP0123112B1 (ja)
JP (1) JPS59176281A (ja)
KR (1) KR910007973B1 (ja)
AT (1) ATE37367T1 (ja)
AU (1) AU558035B2 (ja)
CA (1) CA1236460A (ja)
DE (2) DE3311005A1 (ja)
DK (1) DK163733B (ja)
ES (4) ES8607290A1 (ja)
FI (1) FI82463C (ja)
HU (1) HU191302B (ja)
NO (1) NO840951L (ja)
ZA (1) ZA842165B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
IT1190405B (it) * 1985-10-22 1988-02-16 Recordati Chem Pharm Derivati del flavone
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
IN164232B (ja) * 1986-04-11 1989-02-04 Hoechst India
DE3712369A1 (de) * 1987-04-11 1988-10-27 Bayer Ag Substituierte 5-nitro-1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
US5045551A (en) * 1989-09-19 1991-09-03 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH0413679A (ja) * 1990-05-07 1992-01-17 Wakunaga Pharmaceut Co Ltd 新規ジヒドロピリジン誘導体
DE4321030A1 (de) * 1993-06-24 1995-01-05 Bayer Ag 4-bicyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimittel
DE102005034264A1 (de) * 2005-07-22 2007-02-01 Bayer Healthcare Ag 4-Chromenonyl-1,4-dihydropyridincarbonitrile und ihre Verwendung
DE102005034267A1 (de) 2005-07-22 2007-01-25 Bayer Healthcare Ag 4-Chromenonyl-1,4-dihydropyridine und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201406A (en) * 1963-02-11 1965-08-17 Upjohn Co Pyridylcoumarins
DE3412947A1 (de) * 1984-04-06 1985-10-17 Bayer Ag, 5090 Leverkusen Tetrahydothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
JPH0549671B2 (ja) 1993-07-26
ES8705429A1 (es) 1987-05-01
FI841154A (fi) 1984-09-26
CA1236460A (en) 1988-05-10
FI82463B (fi) 1990-11-30
EP0123112A2 (de) 1984-10-31
HU191302B (en) 1987-02-27
NO840951L (no) 1984-09-26
KR840008023A (ko) 1984-12-12
EP0123112A3 (en) 1987-07-22
ES552231A0 (es) 1987-05-01
AU558035B2 (en) 1987-01-15
ES552232A0 (es) 1987-05-01
ZA842165B (en) 1984-10-31
DE3474144D1 (en) 1988-10-27
DK145384A (da) 1984-09-26
FI841154A0 (fi) 1984-03-22
ATE37367T1 (de) 1988-10-15
JPS59176281A (ja) 1984-10-05
DE3311005A1 (de) 1984-09-27
ES8705430A1 (es) 1987-05-01
ES530802A0 (es) 1984-11-01
FI82463C (fi) 1991-03-11
KR910007973B1 (ko) 1991-10-05
AU2591484A (en) 1984-09-27
HUT34186A (en) 1985-02-28
ES8705428A1 (es) 1987-05-01
ES552230A0 (es) 1987-05-01
ES8607290A1 (es) 1986-06-16
DK145384D0 (da) 1984-02-29
US4540789A (en) 1985-09-10
EP0123112B1 (de) 1988-09-21

Similar Documents

Publication Publication Date Title
US4492703A (en) 4-(2-Substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid esters active on blood circulation
EP0176956B1 (de) Neue Diarylverbindungen
DK163733B (da) Chromon- og thiochromonsubstituerede 1,4-dihydropyridinderivater, laegemidler indeholdende disse derivater og laegemidlernes fremstilling
FR2562892A1 (fr) Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes
US3974158A (en) 2-(Substituted anilino)methylmorpholines
HU178449B (en) Process for preparing 1,4-dihydro-pyridine derivatives containing fluorine
HU186438B (en) Process for the preparation of dimer 1,4-dihydro-pyridine derivatives
HU192406B (en) Process for preparing 1,4-dihydro-pyridine derivatives and pharmaceutical compositions containing such compounds
KR920001137B1 (ko) 크로몬- 및 티오크로몬-치환된 1,4-디하이드로-피리딘-락톤의 제조방법
JPH0629244B2 (ja) 1,4−ジヒドロピリジン誘導体
US4066758A (en) N2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
EP0234196A1 (de) Substituierte 1,4-Dihydropyridin-3-carbonsäurepiperazide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0157324A2 (de) Tetrahydrothienopyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4876255A (en) Substituted 1,4-dihydropyridines for control of circulation and thromboses
US4173630A (en) N2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4125604A (en) N2-Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4628107A (en) Intermediate 8-carboxaldehyde-(-chromone and -thiochromone) derivatives
US4073891A (en) N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
JPS6017782B2 (ja) N↑2−アリ−ルスルホニル−l−アルギニンアミド類及び薬剤として許容され得るその塩
US4647568A (en) Circulation-active hydroxy-tetra-hydropyridinelactones
US4072743A (en) N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4804667A (en) Circulation-active 4-aminoaryldihydropyridine lactones
US4675329A (en) Isopropyl 2-(3-trifluoromethylphenoxy)-ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate as vaso-dilators
RU2036907C1 (ru) 2,6-диметил -3,5-бис (алкоксикарбонил) -4-[полифторалкокси(метокси) -фенил] -1,4-дигидропиридины, проявляющие кардиотоническое и гипертензивное действие
JPH054396B2 (ja)

Legal Events

Date Code Title Description
PTS Application withdrawn